Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Aurisco-Pharma-USFDA

More Like This

PR Newswire associated0

Aurisco sets Goals and Plans for Carbon Neutrality by 2027 and Zero Emissions by 2030

Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence

RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)

PR Newswire associated0

Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities

CARBOGEN AMCIS announces successful ANVISA audit of its facility in China

WuXi Biologics Secures FDA PLI Approval for Five Facilities, First for Commercial PFS Line

ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site